Loading…
Company secures intellectual property protection for its technology.
Autonomix Medical, Inc. (AMIX) announced on June 27, 2025, that it has been granted a patent by the relevant authority. This patent provides the company with intellectual property protection for its innovative medical device technology.
The granted patent enhances Autonomix Medical's competitive position in the healthcare industry, particularly within the medical devices sector. The company now holds a valuable asset that can be leveraged for future growth and development.
As of the latest available data, Autonomix Medical has a free float of 6,533,600 shares and 6,907,700 shares outstanding.
This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.